MME and renal cell carcinoma: CD10 is not useful in the differential diagnosis between clear cell papillary renal cell tumor and TFEB-rearranged renal cell carcinoma since both tumors are typically negative for this marker, but it helps distinguish from TFE3-rearranged renal cell carcinoma, usually positive.